Quick Answer
Opus Genetics, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $14.20 million for the year ending 2025.
- Opus Genetics, Inc. showed an increase of +29.1% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from Opus Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $14.20 million | Fiscal year 2024: $10.99 million | Fiscal year 2023: $19.05 million | Fiscal year 2022: $39.85 million | Fiscal year 2021: $589.0 thousand | Fiscal year 2020: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: